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Adult Congenital Heart Disease
Importance of the Right Ventricle
Carole A. Warnes, MD
Rochester, Minnesota
The right ventricle (RV) is of lesser importance in acquired heart disease, but its role is of increasing importance
in congenital heart disease. It may function as a subpulmonary ventricle or as a subaortic (systemic) ventricle in
transposition complexes. The RV has a remarkable ability to adapt to pressure and volume load, but its size and
function are often overlooked. Patients usually develop symptoms only after RV dysfunction has occurred, and in
many diverse clinical scenarios, late referral is common. Advanced RV enlargement and dysfunction are respon-
sible for not only impaired functional capacity but also lethal ventricular arrhythmias and sudden death. Appro-
priate imaging of the size and function of the RV are important because timely surgery on the pulmonary and
tricuspid valves may preserve RV size and function. Adults with congenital heart disease should be followed at
centers where there is an understanding of these problems so that valvular surgery can be considered when
appropriate. (J Am Coll Cardiol 2009;54:1903–10) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.06.048t
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rn the last 2 decades, many investigations surrounding
cquired cardiac disease have focused on the left ventricle
LV) and the importance of preserving its systolic function.
xamples include coronary revascularization and appropri-
te timing for mitral and aortic valve disease to avoid LV
ysfunction, heart failure, and risk of sudden cardiac death,
hich ensues if surgery is performed too late. In stark
ontrast, the right ventricle (RV) is largely overlooked, and
urgery for tricuspid regurgitation (TR), for example, is
sually reserved for patients who are refractory to medical
herapy, even if the RV dysfunction is severe. The surgical
ortality in these circumstances may approach 30% (1).
hether earlier surgery would improve the surgical mortal-
ty or whether residual RV dysfunction portends a poor
rognosis is unclear. As such, the RV is of secondary
mportance in acquired heart disease, and there is little or no
mpetus to preserve its function.
In adult congenital heart disease, the RV has also been
forgotten,” but in the last decade, increasing attention has
een focused on the RV in an effort to avoid the adverse
utcomes that may be associated with RV dysfunction and
brosis. These outcomes include not only exercise limitation
nd RV failure, but importantly, lethal ventricular ar-
hythmias. In a variety of clinical scenarios, pulmonary
nd tricuspid valve surgery is being performed earlier in
n attempt to “save” the RV, and the surgical mortality in
xperienced centers is acceptably low. Although the
iming of these surgeries remains controversial, it is clear
rom the Divisions of Cardiovascular Diseases and Pediatric Cardiology andf
epartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Manuscript received April 6, 2009; accepted June 3, 2009.hat earlier interventions can have excellent long-term
utcomes.
It is recognized that the RV has a completely different
hape, structure, and contraction pattern than the LV, and
easurement of its size and function to facilitate timing of
urgery is more challenging. Most often it exists as a
ubpulmonary ventricle but may be the subaortic (systemic)
entricle in transposition complexes. This article reviews
ome of the current issues related to the RV and the
mportant role it plays in congenital heart disease.
natomy
he RV is composed of 3 anatomic and functional subunits,
hich include the inlet portion extending from the tricuspid
alve to the insertions of the papillary muscles onto the
entricular wall, the trabecular portion involving the RV
ody and apex (the fundamental component of the pump
echanism), and the outflow or infundibular portion ex-
ending to the pulmonary valve that is generally free of
rabeculations (Fig. 1A). This complex, more triangular
hape of the RV contrasts with the more conical shape of
he LV; when viewed in short axis, the RV has a crescent
hape and “wraps around” the LV (Fig. 1B). The muscular
all of the normal RV is usually 3 to 5 mm in thickness, but
n conditions of pressure overload, the RV wall thickness
ay even exceed that of the LV. The myocardial fiber
rrangement of the RV is different than that of the LV, and
ts contraction relies more heavily on longitudinal shorten-
ng than the circumferential fiber arrangement of the LV
2,3). As a subpulmonary ventricle pumping to a low-
esistance circuit, the RV functions at a lower ejection
raction (EF) than its counterpart. The coronary arteries are
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Adult Congenital Heart Disease November 17, 2009:1903–10concordant; therefore, regardless
of the anatomic arrangement, a
single right coronary artery sup-
plies the RV myocardium, with
the inherent vulnerability to ox-
ygen supply/demand mismatch.
As such, a morphologic RV seems
inherently incapable of function-
ing as a subaortic systemic ventric-
ular pump, although as this review
will discuss, it has the remarkable
capability to adapt and can func-
tion at systemic pressures for
decades.
Imaging
The chest radiograph may be
misleading in the assessment of
RV size because the RV may be
significantly enlarged and may
ompress the LV, resulting in a normal cardiothoracic ratio.
wo-dimensional echocardiography facilitates assessment
f LV size and function, and reliable mathematical models
an be applied because it has a prolate ellipsoid shape. In
ontrast, precise measurements of the RV are challenging
ecause of its complex shape (4). It must be imaged in
ultiple planes, although the short-axis view is usually the
ost helpful. A qualitative visual assessment is usually
pplied, with the RV size being described as either normal
r mildly, moderately, or severely enlarged. If the RV is the
ame size as the LV, it is usually characterized as moderately
nlarged, and if larger than the LV, it is severely enlarged.
unction of the RV is usually characterized as normal or
ildly, moderately, or severely dysfunctional. With serial
ollow-up, there may be little interobserver variability;
owever, among different interpreters and institutions, there
ay be considerable differences in the assessment of RV size
nd function. Because of these limitations, 3-dimensional
chocardiography is being increasingly utilized although not
et well validated.
Magnetic resonance imaging is also increasingly being
sed to assess the RV; although it is often referred to as the
gold standard,” there are difficulties with its use—including
onsiderable interobserver/intraobserver variability (5). En-
ocardial border definition is essential to aid RV volume
alculation, and both trabeculations and papillary muscles in
he RV make this more difficult (6,7). Although many
enters compute RV volumes from short-axis images, there
s not universal consensus (5). The most basal RV slice near
he tricuspid valve is particularly difficult to define; because
his is a large area, the potential for error is significant. The
V outflow may be excluded from the volume measure-
ents if there is an aneurysm of the right ventricular
utflow tract (RVOT), which may occur after patching.
Abbreviations
and Acronyms
AV  atrioventricular
EF  ejection fraction
LV  left ventricle/
ventricular
PS  pulmonary stenosis
PVR  pulmonary valve
replacement
RV  right ventricle/
ventricular
RVOT  right ventricular
outflow tract
TR  tricuspid
regurgitation
VSD  ventricular septal
defect
VT  ventricular
tachycardiancreasingly, as RV end-diastolic volumes are being used to vacilitate decisions about timing of valve surgery in congenital
eart disease, these caveats must be remembered. A consistent
nd reproducible approach should be adopted by all.
Volume-based indexes of RV function have limitations
ecause they are load dependent, and other Doppler mea-
urements may add insights into RV function. These
nclude the dP/dt of the TR velocity and the index of
yocardial performance of the RV (8). Other measure-
ents include tissue Doppler imaging of the tricuspid
nnulus (9) and myocardial acceleration during isovolumic
ontraction (10), which measure intrinsic contractility but
re not used routinely. RV diastolic function may also be
ssessed by Doppler interrogation of hepatic and superior
Figure 1 Pathologic Specimens
(A) Pathologic specimen of the right ventricle with the free wall removed to
demonstrate the 3 anatomic regions. (B) Pathologic specimen of the heart cut
transversely demonstrating the crescent shape of the right ventricle. Photos
courtesy of Dr. W. D. Edwards, consultant in pathology, Mayo Clinic.ena cava inflow patterns as well as the RVOT. The
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November 17, 2009:1903–10 Adult Congenital Heart Diseaseemonstration of atrial contribution to forward flow with
etrograde flow in the superior vena cava suggests restrictive
hysiology in the RV (11).
ulmonary Valve Stenosis (PS)
S exemplifies the ability of the RV to adapt to pressure
verload and is the most common form of RV outflow
bstruction. Obstruction may also occur at the supravalvular
evel; below the valve, obstruction is commonly at the
nfundibular level and is usually secondary to PS. The chest
adiograph often has characteristic features, with a normal
eart size and post-stenotic dilation of the pulmonary artery
Fig. 2). The diagnosis and severity of PS is usually made by
linical examination and confirmed by transthoracic echo-
ardiography as long as multiple windows are explored and
he RV pressure confirmed by the TR velocity.
The RV responds to PS by hypertrophy and maintains its
unction for years even when the pressure is systemic. It is a
isconception that the RV dilates and fails when exposed to
igh pressure; indeed, as long as sinus rhythm is preserved,
nd there is no additional volume lesion, the RV can
aintain good function until the patient is in the fifth
ecade. When the RV pressure exceeds 50% of the systemic
ressure, however, many patients develop symptoms, typi-
ally dyspnea, dizziness, or chest pain.
The first operation for PS was performed in 1948, and
Figure 2 Chest Radiograph of a Patient
With Severe Valvular Pulmonary Stenosis
The heart size is normal even though the right ventricular pressure in this
patient is 150 mm Hg. Note the characteristic post-stenotic dilation of the pul-
monary artery.ubsequent procedures in the early 1950s involved a closed salvotomy. Later, open pulmonary valvotomy yielded supe-
ior results. If the pulmonary annulus is small, a transannu-
ar patch may be needed; if the valve is dysplastic, a
alvectomy may be necessary. These operations always result
n pulmonary regurgitation, which is tolerated well for years.
nitially the RV compensates by dilation but maintains
ontractility and stroke volume. Often decades later, how-
ver, RV systolic function deteriorates, and patients develop
ymptoms, usually dyspnea, fatigue, and atrial arrhythmias.
PS is generally considered a benign lesion, and operations
or PS were considered “curative.” In the Second Natural
istory Study, only 14 of 277 (5%) patients treated surgi-
ally for isolated PS required reintervention at 25-year
ollow-up (12). In the longer term, however, particularly
fter a closed procedure when significant pulmonary regur-
itation is a common sequela, the outcome is not so benign,
nd further surgery may be necessary. In the series by Earing
t al. (13), 21 of 53 (40%) adult patients underwent
ulmonary valve replacement (PVR), with a mean interval
fter initial surgery to the time of PVR of 33 years. Most
atients had moderate or severe RV dilation at the time of
VR, two-thirds were New York Heart Association func-
ional class II or III, and one-half had at least moderate TR
equiring concomitant tricuspid valve annuloplasty. Two
atients in the follow-up group who had not undergone
VR experienced sudden cardiac death, and another 3
eveloped a ventricular arrhythmia. These data are similar
o those in a study of congenital pulmonary valve regurgi-
ation in which 21 of 72 (29%) patients developed symp-
oms after 40 years and the rate of development (hazard
unction) of symptoms was markedly increased after 40
ears (14).
Thus, in unoperated PS, the RV remains well compen-
ated; however, after valvotomy, the resultant pulmonary
egurgitation may cause RV dysfunction. Pulmonary valve
eplacement should be performed before severe RV dysfunc-
ion occurs; otherwise, RV function never recovers. This
mphasizes the importance of lifelong follow-up for these
atients, many of whom consider themselves “cured.” Serial
xercise testing facilitates the detection of subtle decline in
xercise capacity, and echocardiography permits assessment
f RV size and function. Development or progression of
econdary TR should prompt consideration of PVR, and the
nset of atrial arrhythmias should prompt an assessment of
he underlying hemodynamics. The exact timing for PVR
emains controversial because all available bioprosthetic
alves have a finite life expectancy.
The current treatment for severe valvular PS is balloon
alvotomy, which has results comparable to surgical valvot-
my. Current American College of Cardiology/American
eart Association guidelines recommend balloon valvot-
my when the Doppler peak instantaneous gradient across
he pulmonary valve is 60 mm Hg, even if the patient is
symptomatic (15). Whether the resultant pulmonary re-
urgitation will ultimately cause the same problems as
urgical valvotomy remains to be determined.
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Adult Congenital Heart Disease November 17, 2009:1903–10etralogy of Fallot
his anomaly exemplifies the problems that beset the RV
fter surgical repair. Tetralogy is one of the most common
yanotic congenital heart defects and consists of sub-PS
often with coexistent valve and supravalvular stenosis), RV
ypertrophy, a subaortic ventricular septal defect (VSD), and
n aorta that overrides the VSD. Repair of tetralogy was first
ccomplished by Lillehei et al. (16) in 1954 with closure of the
SD and resection of the RVOT stenosis. Relief of the
VOT stenosis may necessitate an RVOT patch when the
ulmonary annulus is small or a more extensive transannular
atch; both procedures distort the pulmonary valve. If the
ulmonary valve itself is abnormal, a pulmonary valvotomy or
ven a valvectomy may be necessary.
Late survival after tetralogy repair is excellent, but like all
atients with repaired congenital heart disease, there are
esidua and sequelae and patients are not completely cured.
n RVOT patch always results in pulmonary regurgitation,
hich is usually well tolerated for many years. The RV
aintains systolic function for a long time unless there is an
dded hemodynamic burden such as peripheral PS that
mpedes forward flow or another volume lesion such as a
esidual VSD. Atrial tachycardia or fibrillation may also
ccelerate RV dysfunction. Often, after 2 decades or so, RV
ontractile function deteriorates, resulting in decreased
troke volume and increased RV end-systolic volumes.
mportantly, severe RV enlargement and severe RV dys-
unction can antedate the onset of symptoms. Most patients
fter tetralogy repair have right bundle branch block on
lectrocardiography, but the wider the QRS, the worse the
V function—the so-called “mechano-electrical interac-
ion” (17). When the QRS duration exceeds 180 ms, patients
re more vulnerable to ventricular tachycardia (VT) and sudden
eath; however, this correlation is inexact in individuals, and
recise risk stratification remains challenging.
As such, patients should be considered for PVR before
here is irreversible RV dysfunction. Certainly PVR should
e performed when patients develop dyspnea, but many
atients with congenital heart disease have no perception of
normal” and may therefore have advanced RV dysfunction
y the time they complain of symptoms. Serial exercise
esting may help to delineate subtle changes in exercise
apacity before the patient becomes symptomatic.
In addition to exercise capacity, the size and function of
he RV help to determine appropriate timing of PVR.
ndications for PVR include moderate to severe RV en-
argement, moderate to severe RV dysfunction, moderate to
evere TR that develops as the RV dilates, and symptomatic
trial and ventricular arrhythmias that usually manifest as
art of the underlying hemodynamic problem.
Usually no single parameter, but several variables, are
onsidered to facilitate correct timing of PVR (15). Coex-
stent PS, although uncommon, may necessitate earlier
peration because the RV then has to withstand both
ressure and volume load, and patients are often symptom- “tic before the RV is severely dilated. When there is
ignificant TR, concomitant repair or replacement of the
ricuspid valve may also be necessary. Cryoablation of the
VOT may be performed to treat ventricular tachyarrhyth-
ias, and a concomitant Maze procedure if there are atrial
rrhythmias can also be accomplished with little prolonga-
ion of the operative time.
Magnetic resonance imaging is increasingly being used to
easure RV volumes and function to facilitate timing of
VR. In 2002, Vliegen et al. (18) demonstrated that after
VR, patients improved their New York Heart Association
unctional classification and RV volumes diminished, but
VEF did not improve. The authors concluded that PVR
hould be performed earlier. In 2004, Geva et al. (19)
eported that all patients with repaired tetralogy who had an
V end-systolic volume index95 ml/m2 had RV dysfunc-
ion and that patients who had an RVEF 35% tended to
ave worse clinical status. Importantly, they also reported
he unfavorable ventricular-ventricular interaction that oc-
urs with severe RV enlargement; if the RVEF was im-
aired, the LVEF was also worse.
More recently, “cut-off” values for RV volumes have been
escribed beyond which the RV size will never normalize.
n a small series, Therrien et al. (20) reported that only
hose with RV end-diastolic volumes 170 ml/m2 normal-
zed their end-diastolic volumes after PVR and only those
ith end-systolic volumes85 ml/m2 could normalize their
nd-systolic volumes. Oosterhof et al. (21) reported that
ven very large RVs get smaller after PVR, but normaliza-
ion of RV size only occurred when the pre-operative RV
nd-diastolic volume was 160 ml/m2. The RVEF did not
mprove, however, and only 17% of patients normalized RV
nd-systolic volumes. More recently the proposed “cut-off”
alue has moved even lower to 150 ml/m2 (22). In none of
hese studies was consistent improvement in RVEF ob-
erved. Because of the challenges of RV measurements
utlined previously, RV volume alone should not be the
nly variable used to determine timing of PVR.
Whether achieving normalization of RV volumes im-
roves long-term outcomes remains uncertain, and there are
o data that preserving RV function by earlier operation
ortends a better prognosis. Although the bad RV is
ssociated with an increased risk for VT and sudden death,
here is no evidence that PVR alone protects against
ubsequent VT. Because QRS duration may be a “proxy” for
V function, PVR alone does not usually result in short-
ning of the QRS duration. A recent nonrandomized study
23) reported that PVR conferred no improvement in
urvival or the incidence of VT compared with controls,
lthough both groups were fairly small and the follow-up
as relatively short. It is possible that in both groups, the
V size and dysfunction were already advanced and surgery
as too late to confer a survival advantage.
Thus, although the “window of opportunity” for PVR is
hifting earlier, we await evidence that earlier surgery to
save” the RV results in improved survival and decreased
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November 17, 2009:1903–10 Adult Congenital Heart Diseasencidence of VT. This may be because surgery is still being
erformed too late, and the focus should be on the preser-
ation of RVEF rather than RV volume. Certainly this is in
ontrast to the LV, for which maintenance of a normal EF
s the “holy grail” of valve intervention. Although normal-
zation of RV volume and RVEF could be achieved with
arlier operation, it remains unproven whether this would
esult in better long-term outcomes, especially because
ulmonary bioprostheses have a limited life span, necessi-
ating reoperation.
bstein Anomaly
bstein anomaly is an uncommon congenital abnormality
hat involves failure of delamination of the tricuspid valve
nd variable degrees of TR. The tricuspid valve is displaced
nferiorly with an “atrialized” RV above and a true RV
elow. In extreme cases, the atrialized portion of the RV can
ccupy more than one-half of the RV volume, and the RV
nlargement may be so pronounced that the ventricular
eptum shifts leftward, compressing the LV. The LV itself
ay also be abnormal (24). The anomaly encompasses a
ariable spectrum, and patients may present in infancy with
yanosis and heart failure, or in adulthood with dyspnea,
atigue, palpitations, or cyanosis when there is an associated
trial septal communication.
Not well recognized as part of the anomaly is the
ccompanying RV myopathy that adds to the propensity for
V dysfunction, in addition to that posed by the TR. The
V is usually very thin walled (Fig. 3) and vulnerable to
rogressive dilation and dysfunction as TR increases. Like
ther congenital heart diseases, subtle decline in exercise
apacity may go unnoticed until severe RV dysfunction and
evere TR supervenes. In addition, the clinical signs of TR
re easily missed because the right atrium is so large and
ncompasses all the volume of the regurgitant jet without
levation of the jugular venous pressure. The TR may also
e underestimated on echocardiography because color flow
ay be laminar with low velocity. For these reasons, adults
ith Ebstein anomaly are often referred late with severe RV
nlargement and dysfunction (Fig. 4). Historically, the
esults of tricuspid valve operation were also poor, in part
ecause of the advanced RV dysfunction, more severe forms
f the anomaly, and worse functional status.
In the current era, however, tricuspid valve repair or
eplacement can be accomplished with a low mortality and
orbidity in experienced centers, particularly when patients
o not have severe pre-operative RV dysfunction. A recent
tudy of 539 patients (25) reported an early mortality of
.3%. Importantly, pre-operative variables of higher mor-
ality included RV and LV dysfunction, emphasizing the
eed for earlier referral and consideration of operation. In
he earlier era, indications for surgery included a cardiotho-
acic ratio on chest radiograph of 65%. In the last decade,
owever, we recognized that when the cardiac silhouette is
o large, the RV is severely enlarged because the LV is ssually relatively small; therefore, when possible, surgery
as performed earlier. Improvement in functional class and
xercise capacity resulted in the majority of patients, and
0-year survival free of any reoperation was 74% (25).
ongenitally Corrected Transposition
his anomaly demonstrates the remarkable ability of the
V to adapt to systemic pressure. It comprises both atrio-
entricular (AV) and ventriculoarterial discordance so that
he right atrium enters the morphologic LV, which gives
ise to the pulmonary artery, and the left atrium enters the
orphologic RV, which gives rise to the aorta. Thus, blood
ows in the normal direction but through the “wrong”
entricle (Fig. 5). Because the tricuspid valve always enters
he morphologic RV, it too is on the left side in the systemic
irculation and is more correctly termed the systemic AV
alve (26). The single right coronary artery supplies the
orphologic RV, making it vulnerable to perfusion mis-
atch and ischemia (27). Interestingly, the contraction
attern of a systemic (subaortic) RV may resemble that of a
ormal LV, with predominant circumferential shortening
ver longitudinal free wall shortening, opposite from the
ormal RV. This may represent an adaptive response to the
Figure 3 Pathologic Specimen Cut in the 4-Chamber
Plane From a Patient With Ebstein Anomaly
The tricuspid valve is displaced markedly inferiorly, and the right ventricular
wall is extremely thin. Photo courtesy of Dr. W. D. Edwards, consultant in
pathology, Mayo Clinic.ystemic load (28).
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Adult Congenital Heart Disease November 17, 2009:1903–10It is a misconception that when the morphologic RV is
he systemic ventricle, it inevitably fails early, and remark-
bly, survival to the seventh and eighth decade has been
eported. An added volume lesion, however, will precipitate
entricular dysfunction, and most commonly, failure of the
orphologic RV occurs as a sequel to systemic AV valve
egurgitation (29). The systemic (tricuspid) valve may have
arked inferior displacement, the so-called “Ebstein-like”
eformity of the systemic AV valve, although the inferior
Figure 4 Chest Radiograph of a 32-Year-Old
Man With Severe Ebstein Anomaly
The patient was referred late with severe right ventricular (RV) enlargement,
severe RV dysfunction, and severe tricuspid regurgitation. He was cyanotic sec-
ondary to a small atrial septal defect and could walk only a few yards.
Figure 5 Congenitally Corrected Transposition
Schematic diagram of a normal heart (left) and congenitally corrected transposition (r
with permission from Warnes (31). Ao  aorta; LA  left atrium; LV  morphologic leisplacement is the only morphologic feature it shares with
bstein anomaly of the right AV valve. In this setting, AV
alve regurgitation is even more likely, and such patients
hould be evaluated regularly. At the earliest sign of dete-
ioration in systemic ventricular function, systemic AV valve
egurgitation should be suspected (30,31).
Much has been written about the importance of early
urgery for mitral regurgitation and the imperative of
aintaining LV function. In stark contrast, however, it is
isappointing that patients with congenitally corrected trans-
osition are often referred for surgery late with severe systemic
V valve regurgitation and advanced ventricular dysfunction.
n a Mayo Clinic series, 59% of patients were referred with
ignificant (grade 3/4) AV valve regurgitation, and more
han one-half of those who needed systemic AV valve replace-
ent were referred late with clinical ventricular dysfunction
6 months (32). Systemic AV valve replacement can be
ccomplished with acceptable mortality in experienced centers,
ut ventricular function remains depressed (33).
An important marker for poor survival was a poor
re-operative systemic EF, and patients surviving operation
re at risk of needing cardiac transplantation in the subse-
uent decade. If systemic AV valve replacement is per-
ormed before the EF is depressed, however, systemic
entricular function may be maintained even in older
atients (Fig. 6).
onclusions
dults with congenital heart disease often have right-sided
ardiac disease, which has a negative impact on long-term
utcomes. This may occur as part of their intrinsic abnor-
which there is both atrioventricular and ventriculoarterial discordance. Reproduced
icle; PT  pulmonary trunk; RA  right atrium; RV  morphologic right ventricle.ight) in
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November 17, 2009:1903–10 Adult Congenital Heart Diseaseality or as a result of prior surgery. When the RV is
ignificantly enlarged and dysfunctional, there is an in-
reased likelihood of exercise limitation, VT, and sudden
eath. Enlargement and dysfunction of the RV may be
asily overlooked, particularly when patients do not com-
lain of symptoms. Patients should be followed at congen-
tal heart disease centers where there is an understanding of
hese problems so that earlier valvular surgery may be
onsidered when appropriate. The precise timing of these
perations remains a “moving target”; although the trend is
o operate earlier to improve RV size and symptoms, we
wait data indicating that preservation of RV function to
mprove outcome and survival should be the goal.
eprint requests and correspondence: Dr. Carole A. Warnes,
ayo Clinic, Gonda 5-368, 200 First Street SW, Rochester,
innesota 55905. E-mail: warnes.carole@mayo.edu.
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